Project Grant R44HL127706

Award Date 4/1/15
Completion Date 7/31/22
Dollars Obligated $1.5M
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
New York, USA
Similar Awards
This federal Project Grant award of $251,156 from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) aims to develop a betavoltaic power source for leadless cardiac pacemakers (LCPs). The project will leverage advanced polyimide packaging and manufacturing methods to create a miniaturized, long-lasting power source for LCPs, reducing their size and extending device lifespan beyond the current 7-10 years provided by lithium-based...
This $606,609 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the CFDA Program 93.286 "Discovery and Applied Research for Technological Innovations to Improve Human Health", aims to develop minimally invasive, wireless, and multi-site photostimulation devices for cardiac resynchronization therapy. The project led by researchers at the University of Chicago will focus on designing and fabricating porosity-based silicon...
This $448,491 project grant awarded by the National Science Foundation's (NSF) Engineering program (CFDA 47.041) aims to develop a novel self-biased high-efficiency radiovoltaic battery based on metal-oxide-semiconductor (MOS) devices using silicon carbide (SiC) semiconductor technology. The primary goal is to create a betavoltaic device capable of reaching a theoretical conversion efficiency of 25% by investigating the properties of the Y2O3/4H-SiC junction and interface, exploring other wide...
This Project Grant award from the National Heart Lung and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $343,203 to Cyion Technologies LLC to develop a novel in vitro electrophysiology system for high-throughput measurement of intracellular action potential (IAP) in human-derived cardiomyocytes. The system leverages a 3D nanoelectrode array (NEA) technology to enable scalable recordings of IAP signals from many individual cardiomyocytes. This...
Bioenno Tech, LLC received a $200,000 project grant award from the Department of Energy Office of Science under the Office of Science Financial Assistance Program (CFDA 81.049) to develop high-energy, high-power solid-state lithium-ion battery cells based on 5V electrode technologies. The award, issued on June 27, 2022, supports research and development activities at Bioenno Tech's facility in Santa Ana, California through March 26, 2023. Specifically, the company will work to advance electric...
The National Science Foundation (NSF) awarded a $274,821 SBIR Phase I grant to Nu Planet Pharmaceutical Radioisotopes, Inc. under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program. The project aims to develop a low-cost isotope battery for long-lived power applications, including deep space, medical, and defense uses. The key outcomes will be the ability to produce radioisotope materials that can provide electrical power for extended durations, enabling new technologies by...
This Project Grant award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $549,943 to the Massachusetts Institute of Technology (MIT) to develop a high-energy, long-duration primary (non-rechargeable) battery with significantly higher energy density than currently available lithium primary batteries. The project aims to advance cathode architecture design and anode stabilization strategies to overcome performance limitations...
The National Science Foundation (NSF) awarded a three-year, $449,999 Project Grant under their Engineering program (CFDA 47.041) to the University of Cincinnati to develop an implantable biosensor platform that can continuously monitor various biomarkers in the body for over a year. The project aims to create a new class of long-lasting aptamer-based sensors protected by robust porous oxide coatings, which would enable the first practical implantable monitoring system for managing chronic...
The U.S. Department of Energy's Advanced Research Projects Agency-Energy (ARPA-E) awarded a $2,301,496 cooperative agreement to Great Lakes Crystal Technologies Inc. to develop high-power diamond transistors with electrical and optical gate control. This project aims to revolutionize power electronics for grid applications by leveraging the superior high-power switching capabilities of diamond-based technology. The proposed solution incorporates sophisticated light-activated switching control to...
This $437,461 Project Grant awarded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports the development of a novel stabilization catheter for His pacing lead implantation. The key product being developed is a sheath with a deployable suction flute that can improve the accuracy and ease of His lead placement for cardiac resynchronization therapy (CRT) in heart failure patients. The goal is to refine the sheath...

HIGH ENERGY DENSITY, LONG LIFE, BETAVOLTAIC POWER CELLS FOR PACEMAKERS AND OTHER IMPLANTABLE DEVICES

Posted 8/10/17, 12:00 AM